Kotaro Suzuki Selected Research

Allylestrenol

7/2006

Recovery of serum prostate specific antigen value after interruption of antiandrogen therapy with allylestrenol for benign prostatic hyperplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kotaro Suzuki Research Topics

Disease

13	Inflammation (Inflammations) 01/2022 - 01/2006
11	Neoplasms (Cancer) 10/2021 - 05/2003
7	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 05/2004
7	Prostatic Neoplasms (Prostate Cancer) 08/2021 - 07/2006
5	Rheumatoid Arthritis 01/2022 - 04/2013
4	Hemorrhage 12/2012 - 05/2004
3	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2019
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 08/2012
3	Shock 03/2013 - 02/2010
3	Testicular Neoplasms (Testicular Cancer) 01/2013 - 05/2003
2	Retinal Detachment (Retinal Detachments) 01/2021 - 12/2019
2	Atopic Dermatitis (Atopic Eczema) 01/2021 - 01/2011
2	Synovitis 01/2021 - 04/2013
2	Contact Dermatitis (Eczema, Contact) 07/2017 - 05/2015
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2016 - 06/2014
2	Azoospermia 01/2013 - 05/2003
2	Anaphylaxis (Anaphylactic Shock) 01/2011 - 08/2008
2	Influenza in Birds (Avian Flu) 07/2009 - 09/2008
2	Glaucoma 01/2008 - 12/2004
1	Varicella Zoster Virus Infection 07/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2022
1	Pain (Aches) 07/2022
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 04/2022
1	Corneal Ulcer 01/2022
1	Infectious Mononucleosis (Glandular Fever) 01/2022
1	Herpetic Keratitis 01/2022
1	Osteoarthritis 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Experimental Arthritis 01/2022
1	Arthritis (Polyarthritis) 01/2022
1	Skin Diseases (Skin Disease) 01/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2021
1	Mediastinal Emphysema (Pneumomediastinum) 12/2021
1	Dermatomyositis (Dermatopolymyositis) 12/2021
1	Myocardial Infarction 10/2021
1	Dermatitis 01/2021
1	Vitreous Detachment (Posterior Vitreous Detachment) 01/2021
1	Proliferative Vitreoretinopathy 01/2021
1	Glomerulonephritis 01/2021
1	Osteophyte 04/2020
1	Obesity 04/2020
1	Hypophysitis 01/2020
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2020
1	Pyelonephritis 01/2020

Drug/Important Bio-Agent (IBA)

8	CytokinesIBA 01/2022 - 09/2006
4	Proteins (Proteins, Gene)FDA Link 03/2014 - 02/2004
3	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 04/2013
3	interleukin-21 (interleukin 21)IBA 10/2021 - 08/2014
3	NivolumabIBA 09/2020 - 01/2020
3	Immunoglobulin E (IgE)IBA 01/2011 - 01/2006
2	DNA (Deoxyribonucleic Acid)IBA 07/2022 - 06/2015
2	Imiquimod (Aldara)FDA LinkGeneric 01/2022 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 07/2017
2	CreatinineIBA 01/2021 - 06/2006
2	Retinaldehyde (Retinal)IBA 01/2021 - 01/2008
2	Interleukin-9 (Interleukin 9)IBA 01/2021 - 04/2017
2	Axitinib (AG 013736)IBA 01/2021 - 09/2020
2	Immune Checkpoint InhibitorsIBA 09/2020 - 01/2020
2	AndrogensIBA 11/2019 - 12/2014
2	Docetaxel (Taxotere)FDA Link 04/2018 - 11/2012
2	Matrix Metalloproteinase 12IBA 07/2017 - 05/2015
1	Antiphospholipid AntibodiesIBA 04/2022
1	Ophthalmic Solutions (Eye Drops)IBA 01/2022
1	SteroidsIBA 01/2022
1	Ointments (Pastes)IBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Neuropilin-2IBA 01/2022
1	CollagenIBA 01/2022
1	Semaphorins (Semaphorin)IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	tofacitinibIBA 12/2021
1	Hormones (Hormone)IBA 08/2021
1	AlbuminsIBA 01/2021
1	Thymic Stromal LymphopoietinIBA 01/2021
1	AutoantibodiesIBA 01/2021
1	FibrinIBA 01/2021
1	ChemokinesIBA 01/2021
1	NPHS2 proteinIBA 01/2021
1	Rheumatoid FactorIBA 04/2020
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2020
1	C-Reactive ProteinIBA 01/2020
1	amrubicinIBA 01/2020
1	PlatinumIBA 01/2020
1	Pituitary HormonesIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020

Therapy/Procedure

8	Therapeutics 07/2022 - 07/2006
8	Drug Therapy (Chemotherapy) 04/2018 - 05/2003
5	Nephrectomy 01/2022 - 05/2004
4	Vitrectomy 01/2021 - 01/2008
3	Castration 11/2019 - 04/2018
3	Aftercare (After-Treatment) 06/2015 - 08/2007
2	Stents 05/2015 - 06/2006
2	Cannula 03/2008 - 08/2007
2	Kidney Transplantation 07/2007 - 06/2006
1	Topical Administration 01/2022
1	Metastasectomy 01/2022
1	Warm Ischemia 10/2021
1	Intraocular Lenses (Intraocular Lens) 01/2021
1	Ureterostomy 01/2020
1	Urinary Diversion (Ileal Conduit) 01/2020